News

Congratulations to Dr. Nicholas Seyfried and Dr. Ola Wojtas for their featured article “In a Sea of CAA Proteins, CRIP1 Surfaces as a Potential Biomarker” on Alzforum!!!

Vascular-enriched proteomes figure

Congratulations to Dr. Nicholas Seyfried and Dr. Ola Wojtas for their featured article “In a Sea of CAA Proteins, CRIP1 Surfaces as a Potential Biomarker” on Alzforum! The article provides a nice summary of the Seyfried lab’s recent medRxiv publication: Multi-scale integration of human brain vasculature and CSF proteomes reveals biomarkers of cerebral amyloid angiopathy […]

Caroline Watson attended MSACL to present her work and the FeMS “Out of the Shadows” Leadership Development Program!

Caroline at MSACL collage

Caroline Watson successfully presented her targeted protein panel work during the Proteomics: Neurology oral session at MSACL in Montreal. She was also selected by the Females in Mass Spectrometry (FeMS) organization to attend their “Out of the Shadows” Leadership Development Program to advance the careers of female scientists.

Check out the Alzheimer’s Association ISTAART Voices Podcast where Dr. Aleksandra Wojtas and Dr. Nicholas Seyfried discuss their latest research investigating the critical role of cerebrovascular dysfunction in Alzheimer’s and related neurodegenerative diseases.

ISTAART Voices Podcast logo

Protein Signatures, Blood Vessels and Alzheimer’s Disease In this episode, Dr. Aleksandra Wojtas and Dr. Nicholas Seyfried discuss their latest research investigating the critical role of cerebrovascular dysfunction in Alzheimer’s and related neurodegenerative diseases. They explain how analyzing the unique protein signatures found within the brain’s blood vessels is uncovering new insights into the early […]

Congratulations to graduate student Fatemeh Seifar on her first-author publication in Alzheimer’s & Dementia journal! This multi-institutional study delivers a comprehensive analysis of the proteomic landscape in Alzheimer’s disease (AD) across diverse racial groups, leveraging data from 1,105 brain tissues. The study reveals no significant racial differences in key AD proteins, including amyloid and tau, but identifies distinct variations in other protein groups associated with race and diagnosis.

Figure 1 from Large-scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity

https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14360